Showing results (1401-1410 of 1,485) with videos related to

Sort By:
Pageof 149
Eclinicalmedicine|July 18, 2022
ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trialJui-Yung Yang, Cha-Chun Chen, Shun-Cheng Chang, et al.
American Journal of Cancer Research|January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinomaPo-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Cancer Medicine|November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levelsPo-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Immunity|May 2, 2025
Interleukin-34-dependent perivascular macrophages promote vascular function in the brainHannah Van Hove, Chaim Glück, Wiebke Mildenberger, et al.
Scientific Reports|April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in TaiwanMing-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Molecular Plant|October 17, 2022
Overproduction of OsRACK1A, an effector-targeted scaffold protein promoting OsRBOHB-mediated ROS production, confers rice floral resistance to false smut disease without yield penaltyGuo-Bang Li, Jia-Xue He, Jin-Long Wu, et al.
Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
Annals of Surgical Oncology|November 30, 2016
Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b PatientsChun-Ta Liao, Yu-Wen Wen, Shu Ru Lee, et al.
The Journal of Infectious Diseases|May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Pageof 149